Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate.
The cost of whole genome sequencing is dropping rapidly. There has been a great deal of enthusiasm about the potential for this technological advance to transform clinical care. Given the interest and significant investment in genomics, this seems an ideal time to consider what the evidence tells us...
Enregistré dans:
Auteurs principaux: | Timothy Caulfield, Jim Evans, Amy McGuire, Christopher McCabe, Tania Bubela, Robert Cook-Deegan, Jennifer Fishman, Stuart Hogarth, Fiona A Miller, Vardit Ravitsky, Barbara Biesecker, Pascal Borry, Mildred K Cho, June C Carroll, Holly Etchegary, Yann Joly, Kazuto Kato, Sandra Soo-Jin Lee, Karen Rothenberg, Pamela Sankar, Michael J Szego, Pilar Ossorio, Daryl Pullman, Francois Rousseau, Wendy J Ungar, Brenda Wilson |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ad7dc7b64fbc41bd87b9096edfe82feb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Neural and behavioral evidence for an intrinsic cost of self-control.
par: Wouter Kool, et autres
Publié: (2013) -
Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference
par: McCabe CF, et autres
Publié: (2012) -
Daily steps and healthcare costs in Japanese communities
par: Shohei Okamoto, et autres
Publié: (2021) -
THE RESEARCH OF USING «THE COST RECOVERY» METHOD IN THE COST MANAGEMENT
par: Y. Vorontsova, et autres
Publié: (2017) -
QUALITY COST REPORTING AS A DETERMINANT OF QUALITY COSTING MATURITY
par: Andrijana Rogošić
Publié: (2021)